Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2026

Summary of Share-based Payment Arrangement, Option, Activity

The following table summarizes option activity under the plans:


	Options Outstanding			Weighted-Average Remaining	Aggregate Intrinsic Value (in Millions)
	Number of Shares	Weighted Average Exercise Price		Contract Term (in Years)

Outstanding as of December 31, 2025	614,849	$	15.44	5.0	$	9.0
Granted	—	—
Exercised	(64,421)	14.61			0.7
Cancelled/Expired	(5)	15.88			—
Outstanding as of March 31, 2026	550,423	15.54		5.2	$	5.8
Vested and exercisable as of March 31, 2026	543,918	$	15.53	5.2	$	5.8

Summary of Unvested Restricted Stock Units Roll Forward

The following table summarizes the RSU and PRSU activity for the three months ended March 31, 2026:


	Number of Shares	Weighted Average Grant-Date Fair Value per Share
Unvested and outstanding as of December 31, 2025	1,328,658	$	27.62
Granted	1,020,365	27.67
Released	(271,478)	24.60
Canceled and forfeited	(11,700)	30.35
Unvested and outstanding as of March 31, 2026	2,065,845	$	28.02

Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount

Total stock-based compensation expense, classified in the accompanying unaudited interim condensed consolidated statements of operations and comprehensive income (loss) was as follows:


	Three Months Ended March 31,
	2026		2025
	(in millions)
Losses and loss adjustment expenses	$	0.2	$	0.3
Insurance related expenses	0.8		1.2
Technology and development	1.4		1.6
Sales and marketing	0.7		1.0
General and administrative	3.4		3.6
Total stock-based compensation expense	$	6.5	$	7.7